CDC reports disparities in maternal health OUD medication treatment
Pregnant people with opioid use disorder are more likely to receive buprenorphine (a recommended treatment) if they are older, white and have public insurance, which may indicate differences in health care access and care, according to preliminary findings from a Centers for Disease Control and Prevention surveillance network used to improve health outcomes among pregnant people with OUD and their children. READ MORE
Related News Articles
Headline
Eilidh Pederson, CEO at Western Wisconsin Health, shares lessons from her unique birthing experience — in which she delivered her own baby — and outlines how…
Headline
A Health Affairs study published Nov. 3 examined an increase in states banning prior authorizations in private insurance plans for opioid use disorder…
Headline
Lindsey Fauveau, M.D., medical director of breast surgical oncology at Woman’s Hospital, shares how the hospital’s state-of-the-art mobile unit brings 3D…
Headline
HHS awards $1.5 billion in opioid response grants to states, tribal communities The Department of Health and Human Services announced yesterday that it…
Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…
Headline
A blog by Julia Resnick, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore…